Clinical Trials Directory

Trials / Unknown

UnknownNCT03236480

The Gut-lung Axis in Chronic Obstructive Pulmonary Disease

Dynamic Changes of the Respiratory Microbiota and Its Relationship to Fecal Microbiota in Chronic Obstructive Pulmonary Disease

Status
Unknown
Phase
Study type
Observational
Enrollment
100 (estimated)
Sponsor
Peking University People's Hospital · Academic / Other
Sex
All
Age
40 Years
Healthy volunteers
Accepted

Summary

Patients with chronic obstructive pulmonary disease (COPD) are 2-3 times more likely to occur together with chronic gastrointestinal tract (GIT) diseases, such as inflammatory bowel disease (IBD) or irritable bowel syndrome (IBS). Similarly, despite many patients have no history of acute or chronic respiratory disease, up to 50% of IBD patients and 33% of IBS patients have pulmonary involvement, such as inflammation or impaired lung function. Increasing evidence indicated chronic gut and lung disease share key conceptual features with the disorder and dysregulation of the microbial ecosystem. However, the underlying mechanisms are not well understood. Our study is aimed to elucidate the intimate relationship between the gastrointestinal tract and respiratory tract, and uncover the mechanisms by which the gut microbiota affects the immune responses in the lungs, and vice versa.

Conditions

Timeline

Start date
2017-01-01
Primary completion
2018-07-01
Completion
2019-01-01
First posted
2017-08-02
Last updated
2017-08-02

Locations

1 site across 1 country: China

Source: ClinicalTrials.gov record NCT03236480. Inclusion in this directory is not an endorsement.